T. Brady

发表

Oxidative stress in toxicology: established mammalian and emerging piscine model systems.

E. Levin, K. Kelly, Kimberly M Harris, 1998, Environmental health perspectives.

Extracellular superoxide dismutase deficiency worsens outcome from focal cerebral ischemia in the mouse

J. Crapo, R. Pearlstein, H. Sheng, 1999, Neuroscience Letters.

Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-κB activation.

J. Crapo, Ling-Yi L Chang, B. Day, 1997, American journal of physiology. Lung cellular and molecular physiology.

Randomized Phase 2 Trial of Reproxalap, a Novel Reactive Aldehyde Species Inhibitor, in Patients with Noninfectious Anterior Uveitis: Model for Corticosteroid Replacement

C. Foster, D. Chu, J. Sheppard, 2020, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

Nitric oxide inhalation transiently elevates pulmonary levels of cGMP, iNOS mRNA, and TNF-α.

J. Crapo, R. Mercer, T. Brady, 1998, American journal of physiology. Lung cellular and molecular physiology.

Nitric oxide inhalation transiently elevates pulmonary levels of cGMP, iNOS mRNA, and TNF-alpha.

J. Crapo, R. Mercer, T. Brady, 1998, The American journal of physiology.

Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation.

L. Chang, J. Crapo, B. Day, 1997, The American journal of physiology.

Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NFk B activation

J. Crapo, Ling-Yi L Chang, B. Day, 1997 .

Reproxalap Activity and Estimation of Clinically Relevant Thresholds for Ocular Itching and Redness in a Randomized Allergic Conjunctivitis Field Trial

K. Nichols, C. Starr, P. Gomes, 2022, Ophthalmology and Therapy.

Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial.

A. Shields, J. Sheppard, P. Karpecki, 2021, American journal of ophthalmology.

Molecular Manipulations of Extracellular Superoxide Dismutase: Functional Importance for Learning

J. Crapo, E. Levin, S. Marklund, 1998, Behavior genetics.

Early Onset and Broad Activity of Reproxalap in a Randomized, Double-Masked, Vehicle-Controlled Phase 2b Trial in Dry Eye Disease.

J. Sheppard, J. Tauber, T. Brady, 2021, American journal of ophthalmology.

A Randomized Double-Masked Phase 2a Trial to Evaluate Activity and Safety of Topical Ocular Reproxalap, a Novel RASP Inhibitor, in Dry Eye Disease

J. Sheppard, T. Brady, D. Clark, 2021, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

A Post-Acute Ocular Tolerability Comparison of Topical Reproxalap 0.25% and Lifitegrast 5% in Patients with Dry Eye Disease

P. Karpecki, D. McMullin, T. Brady, 2021, Clinical ophthalmology.